Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Public ClinicalTrials.gov record NCT02171156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Study identification
- NCT ID
- NCT02171156
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- nintedanib Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- May 7, 2017
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1199.177.1003 Boehringer Ingelheim Investigational Site | Winter Park | Florida | — | — |
| 1199.177.1012 Boehringer Ingelheim Investigational Site | Skokie | Illinois | — | — |
| 1199.177.1014 Boehringer Ingelheim Investigational Site | Muncie | Indiana | — | — |
| 1199.177.1002 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 1199.177.1011 Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| 1199.177.1022 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 1199.177.1067 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02171156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02171156 live on ClinicalTrials.gov.